An Austrian study demonstrates an anti-tumor effect of certain nature-derived cyclic peptides. The study, which has now been published internationally, not only demonstrates the inhibition of cell division by these peptides, ...
Sep 13, 2022
0
22
"Why did my child get cancer?"
Sep 8, 2022
0
35
Patients with Hodgkin lymphoma (HL) are more likely to suffer from mental-health and substance-abuse disorders than the general population. Calling for more attention to mental health, a study published August 2 in Cancer ...
Aug 15, 2022
0
10
The age-adjusted incidence rate of anaplastic large-cell lymphoma (ALCL) of the breast is increasing rapidly in the United States, according to a research letter published online July 21 in JAMA Oncology.
Jul 26, 2022
0
2
Treatment advances have improved the survival of individuals with Hodgkin lymphoma (HL)—a type of cancer that affects the lymphatic system—but therapies can increase patients' risk of developing heart problems. A recent ...
Jul 25, 2022
0
5
For patients with stage III or IV Hodgkin lymphoma, brentuximab vedotin is associated with a survival advantage, according to a study published online July 13 in the New England Journal of Medicine.
Jul 14, 2022
0
1
New light is being shed on the mechanisms underlying the malignant transformation of lymphomas, paving the way for a promising therapeutic target, thanks to research conducted by a team led by Université de Montréal professor ...
Jul 11, 2022
0
25
There is considerable variation in the management of mantle cell lymphoma across different clinical settings, and some strategies do not always conform with what might be expected, according to an analysis by investigators ...
Jun 28, 2022
0
5
Among pregnancies complicated by cancer, the risks for severe maternal morbidity and mortality are increased, according to a research letter published online June 16 in JAMA Oncology.
Jun 22, 2022
0
3
Arsenic seems to have a dual effect on carcinogenesis, according to a study recently published in Frontiers in Public Health.
Jun 20, 2022
0
2
